Kidd血型抗原弱表达三代基因测序（TGS）与血清学结果对照分析*

doi:10.3969/j.issn.1671-2587.2025.02.006

临床输血与检验 ›› 2025, Vol. 27 ›› Issue (2): 179-185.DOI: 10.3969/j.issn.1671-2587.2025.02.006

Kidd血型抗原弱表达三代基因测序（TGS）与血清学结果对照分析^*

李菲¹, 古丽米热·买买提吐尔干², 孔朝明³, 邱进¹, 王儒彬¹, 赵铁锁⁴, 陈伟¹

¹新疆维吾尔自治区人民医院输血科,新疆乌鲁木齐 830001;
²新疆克孜勒苏柯尔克孜自治州人民医院输血科,新疆克孜勒苏柯尔克孜自治州 845350;
³克拉玛依市中心医院输血科,新疆克拉玛依 834000;
⁴新乡医学院基础医学院免疫学系,河南新乡 453000

收稿日期:2024-11-08 出版日期:2025-04-20 发布日期:2025-04-17
通讯作者: 陈伟,主要从事临床输血治疗与血型免疫血清学及基因检测工作,（E-mail）29286889@qq.com。
作者简介:李菲,主要从事血型免疫血清学及临床输血研究,（E-mail）52993389@qq.com。
基金资助:
*本课题受新疆维吾尔自治区自然科学基金项目（No.2022D01C637）资助

Comparative Analysis of Third-generation Gene Sequencing (TGS) and Serological Findings for Weakly Expressed Kidd Blood Group Antigen

LI Fei¹, GULIMIRE Maimaitituergan², KONG Zhaoming³, QIU Jin¹, WANG Rubin¹, ZHAO Tiesuo⁴, CHEN Wei¹

¹Department of Blood Transfusion, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830001;
²Department of Blood Transfusion,Kizilsu Kirgiz Autonomous Prefecture People's Hospital, Kizilsu Kirgiz Autonomous Prefecture, Xinjiang 845350;
³Department of Blood Transfusion, Karamay Central Hospital, Karamay, Xinjiang 834000;
⁴Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan 453000

Received:2024-11-08 Online:2025-04-20 Published:2025-04-17

摘要/Abstract

摘要： 目的探讨三代基因测序技术（TGS）在Kidd血型抗原弱表达样本中检测的临床意义。方法收集新疆自治区人民医院就诊患者样本并收集患者信息,应用血清学方法检测Jk^a、Jk^b抗原,对结果弱表达样本9例进行Kidd血型基因全长单分子实时测序技术（第三代高通量测序）获得其基因多态性并统计分析。结果获得此次检测Kidd血型基因主要突变位点：c.588A>G、c.838G>A、c.130G>A;此外还发现5例样本带有新的基因突变类型,其中2例为纯合子,3例为杂合子,新的突变基因型为：c.499A>G、c.588A>G、c.838G>A,主要见于Jk（b+）表型,等位基因名称为JK*02.NEW,9例样本中有7例基因检测结果与血清学结果不同,且均带有ISBT记录或未记录的基因突变位点,同时汇总并分析了突变基因位点特异性及其对应氨基酸改变情况。结论本研究探索了新疆人群红细胞血型Kidd基因的突变、剪切、折叠以及氨基酸序列,为进一步了解本地区血型特异性奠定基础,为今后构建三维蛋白模型提供了依据。

关键词: Kidd血型, 抗原, 基因, 氨基酸

Abstract: Objective To investigate the clinical significance of third-generation gene sequencing (TGS) in detecting Kidd blood group antigen in weakly expressed samples. Methods Samples of patients in Xinjiang Autonomous Region People's Hospital were collected, Jka and Jkb antigens were detected by serological methods, and 9 cases of weakly expressed samples of Kidd blood group genes were subjected to full-length single-molecule real-time sequencing technology (third-generation high-throughput sequencing) to obtain their gene polymorphisms and statistically analyzed. Results The main mutation sites of the Kidd blood group gene were detected in this study: c.588A>G, c.838G>A, and c.130G>A. In addition, 5 samples were found to have new gene mutation types, with 2 being homozygous and 3 heterozygous. The new mutation gene types were: c.499A>G, c.588A>G, and c.838G>A, which are mainly seen in the Jk(b+) phenotype. The allele name for the new mutation is JK*02.NEW. In 9 samples, 7 of the genetic test results were different from the serological results, and all of them had ISBT-recorded or unrecorded gene mutation sites. At the same time, the specificity of the mutation gene sites and the corresponding amino acid changes were summarized and analyzed. Conclusion The present study investigated the mutation, splicing, folding, and amino acid sequence of the Kidd gene in the Xinjiang population. This research lays a solid foundation for gaining further insights into the specificity of blood groups in this region and provides a fundamental basis for future construction of three-dimensional protein models.

Key words: Kidd blood type, Antigen, Genes, Amino acid

中图分类号:

R446

李菲, 古丽米热·买买提吐尔干, 孔朝明, 邱进, 王儒彬, 赵铁锁, 陈伟. Kidd血型抗原弱表达三代基因测序（TGS）与血清学结果对照分析^*[J]. 临床输血与检验, 2025, 27(2): 179-185.

LI Fei, GULIMIRE Maimaitituergan, KONG Zhaoming, QIU Jin, WANG Rubin, ZHAO Tiesuo, CHEN Wei. Comparative Analysis of Third-generation Gene Sequencing (TGS) and Serological Findings for Weakly Expressed Kidd Blood Group Antigen[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2025, 27(2): 179-185.

参考文献

[1] LAWICKI S,COVIN R B,POWERS A A.The Kidd(JK)blood group system[J].Transfus Med Rev,2017,31(3): 165-172.
[2] HEATON D C,MCLOUGHLIN K.Jk(a-b-)red blood cells resist urea Lysis[J].Transfusion,1982,22(1):70-71.
[3] LEE E S,MCHENRY A,SIDDON A,et al.Renal allograft rejection with thrombotic microangiopathy associated with a Kidd blood group system alloantibody[J].Am J Clin Pathol,2021,156(Supplement_1):S159-S160.
[4] 李菲,施丽,朱蓉,等.新疆地区Kell(K)血型及Rh(D)血型抗原及基因频率调查[J].中国实验血液学杂志,2023,31(6): 1825-1830.
[5] International Society for Blood Transfusion.009 JK alleles.v8.2 31-DEC-2023[R/OL].(2023-12-31)[2024-09-10] Available from https://www.isbtweb.org/resource/009jk.html.
[6] BARROS M M O.Kidd system antigens and kidney disease[J].Rev Bras Hematol Hemoter,2017,39(4):293-294.
[7] 中华医学会心血管病学分会介入心脏病学组,中华医学会心血管病学分会动脉粥样硬化与冠心病学组,中国医师协会心血管内科医师分会血栓防治专业委员会,等.稳定性冠心病诊断与治疗指南[J].中华心血管病杂志,2018, 46(9):680-694.
[8] MANRAI P A,SIDDON A J,HAGER K M,et al.Development of anti-Jk3 associated with silenced Kidd antigen expression and a novel single nucleotide variant of the JK gene[J].Immunohematology,2021,37(3):109-112.
[9] DINARDO C L,OLIVEIRA T G M,KELLY S,et al. Diversity of variant alleles encoding Kidd,Duffy,and Kell antigens in individuals with sickle cell disease using whole genome sequencing data from the NHLBI TOPMed Program[J].Transfusion,2021,61(2):603-616.
[10] WU P C,CHYAN T W,FENG S H,et al.Genotyping and serotyping profiles showed weak Jk^a presentation for previously typed as Jknull donors[J].Vox Sang,2019, 114(3):268-274.
[11] 梁爽,莫春妍,刘笑阳,等.Junior血型基因检测技术的建立与1例部分DVI.3型且Jr(a-)稀有血型的鉴定[J].中华医学遗传学杂志,2024,41(1):52-58.
[12] GENOMES PROJECT CONSORTIUM 1 0 0 0,AUTON A,BROOKS L D,et al.A global reference for human genetic variation[J].Nature,2015,526(7571):68-74.
[13] GUEUNING M,THUN G A,TROST N,et al.Resolving genotype-phenotype discrepancies of the Kidd blood group system using long-read nanopore sequencing[J].Biomedicines,2024,12(1):225.
[14] BEYTER D,INGIMUNDARDOTTIR H,ODDSSON A, et al.Long-read sequencing of 3,622 Icelanders provides insight into the role of structural variants in human diseases and other traits[J].Nat Genet,2021, 53(6):779-786.
[15] COLLINS R L,BRAND H,KARCZEWSKI K J,et al.A structural variation reference for medical and population genetics[J].Nature,2020,581(7809):444-451.
[16] SOLEIMANI R,CABO J,FRELIK A,et al.SLC14A1 gene sequencing shows the JK*01W.06 allele in a JK1 patient with an anti-JK1[J].Hematol Transfus Cell Ther,2024, 46(Suppl 5):S278-S283.
[17] ZHANG Z,AN H H,VEGE S,et al.Accurate long-read sequencing allows assembly of the duplicated RHD and RHCE genes harboring variants relevant to blood transfusion[J].Am J Hum Genet,2022,109(1):180-191.
[18] THUN G A,GUEUNING M,SIGURDARDOTTIR S,et al.Novel regulatory variant in ABO intronic RUNX1 binding site inducing A3 phenotype[J].Vox Sang,2024, 119(4):377-382.
[19] SHAO L N,YANG Y C,XIA Y X,et al.Novel missense mutation c.797T>C(p.Met266Thr) gives rise to the rare B(A)phenotype in a Chinese family[J].Vox Sang,2024, 119(4):383-387.
[20] HAIDAR M N,ISLAM M B,CHOWDHURY U N,et al.Network-based computational approach to identify genetic links between cardiomyopathy and its risk factors[J].IET Syst Biol,2020,14(2):75-84.

Kidd血型抗原弱表达三代基因测序（TGS）与血清学结果对照分析^*

Comparative Analysis of Third-generation Gene Sequencing (TGS) and Serological Findings for Weakly Expressed Kidd Blood Group Antigen

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们

[1]	任道菊, 杨金华, 李小薇, 肖军, 李翠莹. 应用孕妇外周血cff-DNA检测胎儿RHD血型基因的方法学研究^*[J]. 临床输血与检验, 2025, 27(2): 163-168.
[2]	田稳, 徐宁, 吴天鸽, 史鸣昊, 李峣, 裴笑仙, 于娜. 4例A抗原表达减弱样本的血清学特点及基因序列分析^*[J]. 临床输血与检验, 2025, 27(2): 186-190.
[3]	赖冬娣, 钟明璐, 董涵, 彭伟康, 魏亚明, 苑召虎. Sema7a蛋白作用机制研究进展^*[J]. 临床输血与检验, 2025, 27(2): 234-246.
[4]	李峣, 史鸣昊, 沈忠军, 王欣, 赵丽艳. ABO基因启动子甲基化在肿瘤患者ABO血型抗原表达减弱中的作用和机制的研究进展^*[J]. 临床输血与检验, 2025, 27(2): 283-288.
[5]	赵亚玲, 张媛媛, 邵伟, 王子夜, 马斯禹, 王艳侠, 江欣, 甘佳. AB血型个体ABO抗原减弱的原因与探讨^*[J]. 临床输血与检验, 2025, 27(1): 76-82.
[6]	王超, 吕蓉, 胡晓玉, 赵娜娜. CD36抗原缺失Ⅰ型4种碱基突变及蛋白结构生物信息学分析^*[J]. 临床输血与检验, 2024, 26(6): 726-734.
[7]	郑妍, 王文婷, 杨龙飞, 王琼, 穆士杰. 8例RhD变异型的血清学特征及基因序列分析[J]. 临床输血与检验, 2024, 26(6): 762-765.
[8]	李艳, 周丽玲, 马肇泽, 祝凯捷, 王辰龙. 25例B亚型/AB亚型的ABO基因序列分析^*[J]. 临床输血与检验, 2024, 26(6): 787-791.
[9]	乔艳辉, 郭伟鹏, 徐保红, 木耶赛尔·伊斯马依力. 新疆地区249例RhD变异型基因分型研究^*[J]. 临床输血与检验, 2024, 26(5): 645-650.
[10]	毛伟, 蒋玉林, 朱传福, 叶欣, 谢毓滨, 李晓丰, 吕蓉, 齐珺, 冯智慧, 苏湘辉, 徐筠娉, 汤龙海, 徐晶, 谭茜茜, 朱发明. 国内血小板基因库建设及应用的现状研究^*[J]. 临床输血与检验, 2024, 26(5): 656-660.
[11]	杨颖, 李子涵, 丁旭苹, 张嘉敏, 李勤, 郭忠慧, 赵俸涌, 杨启修, 王晨, 路丽明, 朱自严. 肿瘤抗原肽的HLA限制性确认和诱导反应性T细胞杀瘤能力评估^*[J]. 临床输血与检验, 2024, 26(4): 433-439.
[12]	冯智慧, 卜祥茂, 浑守永, 于淑红, 庄文华, 宿军, 张韦, 耿微. 山东省ABO亚型等位基因的分析研究^*[J]. 临床输血与检验, 2024, 26(4): 479-483.
[13]	李素萍, 胡晓玉, 方烨, 陈志超, 蒋菲菲, 王婷. 献血者HEV感染合并HBV感染的特征分析^*[J]. 临床输血与检验, 2024, 26(4): 505-510.
[14]	红细胞血型抗原拓展匹配适用范围中国专家共识编写组. 红细胞血型抗原拓展匹配适用范围中国专家共识[J]. 临床输血与检验, 2024, 26(3): 289-298.
[15]	廉雪, 张丹, 温玉洁, 范成艳, 王东梅, 刘娜, 张荣芳, 贾延军. Oxford Nanopore Technology在HLA-DPB1模棱两可基因分型中的应用初探[J]. 临床输血与检验, 2024, 26(3): 365-370.